# Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study

> **NCT04884217** · PHASE2 · UNKNOWN · sponsor: **PharmaDax Inc.** · enrollment: 80 (estimated)

## Conditions studied

- Dry Eye Syndrome
- Keratoconjunctivitis Sicca

## Interventions

- **DRUG:** Pro-ocular™ Topical Gel
- **DRUG:** Placebo Topical Gel

## Key facts

- **NCT ID:** NCT04884217
- **Lead sponsor:** PharmaDax Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-20
- **Primary completion:** 2021-10-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04884217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04884217, "Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04884217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*